Taken all together, D2R-βarr2 biased ligands have the potential to normalize the levels of dopamine neurotransmission in the dopamine-excessive striatal region and dopamine-deficient cortical region simultaneously, and provide safer and more broadly effective therapies for mental disorders. Here, DRD2 is linked to psychiatric disorder.